Author:
Li Lin,Zhou Donghai,Liu Qiuping,Li Dianming,Wang Qiao,Shi Xiaowei,Wen Chengping,Huang Lin
Abstract
Abstract
Background
Rheumatoid arthritis (RA), is an autoimmune inflammatory disease with increasing global morbidity and high disability. Early treatment is an effective intervention to slow down joint deformation. However, as for early RA and pre-RA patients, it sometimes takes a long time to make a definite diagnosis and few guidelines have made suggestion for these suspected or early phrase individuals. Yunpi-Qufeng-Chushi-Prescription (YQCP) is an optimization of the traditional formula, Cangzhu Fangfeng Tang which is effective for arthromyodynia management.
Methods
In this study, LC-MS identify the main component of YQCP. Ingredients of the 11 herbs were collected from Traditional Chinese Medicine Integrated Database (TCMID). Targets of these ingredients were collected from two source, TCMID and PharmMapper. Microarray of 20 early untreated RA patients and corresponding health control were download from NCBI Gene Expression Omnibus (GEO) database to defined the differential expressed genes. Gene ontology analysis and KEGG enrichment analysis were carried out for the YQCP. Protein-protein interactions (PPIs) networks were constructed to identify the hub targets. At last, molecular docking (MD) were conducted to further verified the the possibility of YQCP for RA therapy.
Result
The study indicated that by acting on hub targets such as C3, EGFR, SRC and MMP9, YQCP may influence the mature of B cells and inhibit B cell-related IgG production, regulate oxidative stress and modulate activity of several enzymes including peroxidase and metallopeptidase to delay the occurrence and progress of RA and benefit the pre-RA or early RA patients.
Conclusion
YQCP is a potential effective therapy for prophylactic treatment of RA.
Publisher
Springer Science and Business Media LLC
Subject
Complementary and alternative medicine
Reference46 articles.
1. Smith E, Hoy D, Cross M, Merriman TR, Vos T, Buchbinder R, et al. The global burden of gout: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(8):1470–6. https://doi.org/10.1136/annrheumdis-2013-204647.
2. McInnes IB, Schett G. Mechanisms of disease the pathogenesis of rheumatoid arthritis. New Engl J Med. 2011;365(23):2205–19. https://doi.org/10.1056/NEJMra1004965.
3. Paulissen SMJ, van Hamburg JP, Dankers W, Lubberts E. The role and modulation of CCR6+Th17 cell populations in rheumatoid arthritis. Cytokine. 2015;74(1):43–53. https://doi.org/10.1016/j.cyto.2015.02.002.
4. Prodinger B, Ndosi M, Nordenskiold U, Stamm T, Persson G, Andreasson I, et al. Rehabilitation provided to patients with rheumatoid arthritis: a comparison of three different rheumatology clinics in Austria, Sweden and the Uk from the perspectives of patients and health professionals. J Rehabil Med. 2015;47(2):174–82. https://doi.org/10.2340/16501977-1914.
5. Sun E, Negi A, Davies R. An audit of current clinical practice in the rheumatology Department of University Hospital Wales against the top ten quality standards for rheumatoid arthritis as defined by the British Society for Rheumatology. Rheumatology. 2015;54:103.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献